Urology - urothelial cancer, Malmö
1 – 10 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Applicability of the European Association of Urology 2021 Prognostic Model for Non–muscle-invasive Bladder Cancer in a Swedish Population-based Cohort
- Contribution to journal › Letter
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
- Contribution to journal › Article
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : Summary of the 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer : A nationwide population-based cohort study
- Contribution to journal › Article
-
Mark
Molecular Subtypes of Muscle-Invasive Bladder Cancer
(2025) p.279-295
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
- Contribution to journal › Debate/Note/Editorial
-
Mark
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer : A Nationwide Population-based Study
- Contribution to journal › Article
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
